Treating cancer with fewer toxic side effects

Health Report - Separate stories podcast

Innhold levert av Australian Broadcasting Corporation and ABC listen. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Australian Broadcasting Corporation and ABC listen eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

2d ago 9:41

MP3•Episoder hjem

Hodgkin lymphoma is a cancer that typically affects young adults.

Because of this, there are many things to consider before treatment starts – not just how effective it will be, but its long-term impacts.

Australian researchers have been part of a clinical trial to find effective first-line treatments for the disease that prevent toxic side effects.

Guest

Professor Mark Hertzberg, clinical haematology at Prince of Wales Hospital and UNSW

References

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21)

1368 episoder

#Health and Well-Being #Science #Fitness #Australia #Medicine #Australian Broadcasting Corporation #ABC listen